Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration

Nature Genetics

Volumn 28, Issue 2, 2001, Pages 131-138

  Oosthuyse, Bert ^a   Moons, Lieve ^a   Storkebaum, Erik ^a   Beck, Heike ^b   Nuyens, Dieter ^a   Brusselmans, Koen ^a   Dorpe, Jo Van ^c   Hellings, Peter ^c   Gorselink, Marchel ^d   Heymans, Stéphane ^a   Theilmeier, Gregor ^a   Dewerchin, Mieke ^a   Laudenbach, Vincent ^e   Vermylen, Patrick ^c   Raat, Harold ^f   Acker, Till ^b   Vleminckx, Vicky ^c   Bosch, Ludo Van Den ^c   Cashman, Neil ^g   Fujisawa, Hajime ^h   Drost, Maarten R ^d   Sciot, Raf ^c   Bruyninckx, Frans ^c   Hicklin, Daniel J ⁱ   Ince, Can ^f   Gressens, Pierre ^e   Lupu, Florea ^j   Plate, Karl H ^b   Robberecht, Wim ^c   Herbert, Jean Marc ^k   Collen, Désiré ^a   Carmeliet, Peter ^a   more..

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d MAASTRICHT UNIVERSITY   (Netherlands)

^e HÔPITAL ROBERT DEBRÉ   (France)

^f UNIVERSITY OF AMSTERDAM   (Netherlands)

^g UNIVERSITY OF TORONTO   (Canada)

^h NAGOYA UNIVERSITY   (Japan)

ⁱ ELI LILLY AND COMPANY   (United States)

^j THROMBOSIS RESEARCH INSTITUTE   (United Kingdom)

^k SANOFI   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

AMYOTROPHIC LATERAL SCLEROSIS; ANGIOGENESIS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; GENE EXPRESSION; HYPOXIA; MOTOR NEURON DISEASE; MOUSE; MUSCLE WEAKNESS; NERVE CELL NECROSIS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; AXONS; BINDING SITES; CELL HYPOXIA; ELECTROPHYSIOLOGY; ENDOTHELIAL GROWTH FACTORS; HUMANS; LYMPHOKINES; MICE; MICE, KNOCKOUT; MOTOR NEURONS; MUSCLE CONTRACTION; MUSCLE FIBERS; MUSCULAR ATROPHY; NERVE DEGENERATION; NERVE TISSUE PROTEINS; NEUROPILIN-1; PERIPHERAL NERVES; PROMOTER REGIONS (GENETICS); RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; RESPONSE ELEMENTS; SEQUENCE DELETION; SPINAL CORD; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

ANIMALIA;

EID: 0034978562     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/88842     Document Type: Article

References (46)

1. Mechanisms of angiogenesis and arteriogenesis
2. Clinical applications of angiogenic growth factors and their inhibitors
3. Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: Functional competition of collapsin-1 and vascular endothelial growth factor-165
4. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform- specific receptor for vascular endothelial growth factor
5. Vegf antagonism reduces edema formation and tissue damage after ischemia/reperfusion injury in the mouse brain
6. Expression of angiogenic factors in rabbit spinal cord after transient ischaemia
7. Favorable effect of Vegf gene transfer on ischemic peripheral neuropathy
8. Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system
9. Vascular endothelial growth factor: Direct neuroprotective effect in in vitro ischemia
10. Ischemia-driven angiogenesis
11. Expression of hypoxia-inducible factor 1: Mechanisms and consequences
12. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
13. Interindividual heterogeneity in the hypoxic regulation of VEGF: Significance for the development of the coronary artery collateral circulation
14. Pathogenesis of amyotrophic lateral sclerosis: A critical review
15. Animal models for motor neuron disease
16. Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis
17. Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis
18. Systemic hypoxia changes the organ-specific distribution of vascular endothelial growth factor and its receptors
19. A new transacting factor that modulates hypoxia-induced expression of the erythropoietin gene
20. Translation of vascular endothelial growth factor mRNA by internal ribosome entry: Implications for translation under hypoxia
21. Hypoxic stabilization of vascular endothelial growth factor mRNA by the RNA-binding protein HuR
22. Activator-protein-1 binding potentiates the hypoxia-induciblefactor-1- mediated hypoxia-induced transcriptional activation of vascular- endothelial growth factor expression in C6 glioma cells
23. Development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis
24. Neuronal intermediate filaments
25. Mechanisms for neuronal degeneration in amyotrophic lateral sclerosis and in models of motor neuron death
26. Lumbar motoneurons of man: 1) number and diameter histogram of alpha and gamma axons of ventral root
27. Neuroblastoma x spinal cord (NSC) hybrid cell lines resemble developing motor neurons
28. Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1
29. Evolution of motor and sensory deficits in amyotrophic lateral sclerosis estimated by neurophysiological techniques
30. Midbrain dopaminergic neuronal degeneration in a transgenic mouse model of familial amyotrophic lateral sclerosis
31. Absence of neurofilaments reduces the selective vulnerability of motor neurons and slows disease caused by a familial amyotrophic lateral sclerosis-linked superoxide dismutase 1 mutant
32. Neuronal Vegf expression correlates with angiogenesis in postnatal developing rat brain
33. Spinal cord ischemia. Development of a model in the mouse
34. Imbalance of oxygen activation and energy metabolism as a consequence or mediator of aging
35. Immunohistochemical nitrotyrosine distribution in neonatal rat cerebrocortical slices during and after hypoxia
36. Reactive oxygen species and the neurodegenerative disorders
37. Age-dependent defect in VEGF expression is associated with reduced HIF1a activity
38. Interleukin-1beta and tumor necrosis factor-alpha stimulate DNA binding of hypoxia-inducible factor-1
39. Neuropilin is a receptor for the axonal chemorepellent Semaphorin III
40. Semaphorin signaling: A little less per-plexin
41. Semaphorins and their receptors in vertebrates and invertebrates
42. Cell type specific upregulation of vascular endothelial growth factor in an MCA-occlusion model of cerebral infarct
43. Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188
44. Accurate measurements of in situ isometric contractile properties of hind limb plantar and dorsal flexor muscle complex of intact mice
45. Glial cells potentiate kainate-induced neuronal death in a motoneuron- enriched spinal coculture system